Email Alert | RSS    帮助

中国防痨杂志 ›› 2021, Vol. 43 ›› Issue (12): 1322-1326.doi: 10.3969/j.issn.1000-6621.2021.12.016

• 临床病例讨论 • 上一篇    下一篇

结核性毁损肺并发细小病毒B19感染和重度血小板减少症一例的临床诊治分析

邱君克, 潘晓鸿, 汪彩红, 毛敏杰()   

  1. 浙江大学医学院附属杭州市胸科医院结核ICU
  • 收稿日期:2021-08-10 出版日期:2021-12-10 发布日期:2021-12-01
  • 通信作者: 毛敏杰 E-mail:maominjie0909@163.com
  • 基金资助:
    杭州市卫生计生科技计划一般项目(OO20190385);杭州市科技局一般项目(20191203B127)

Analysis of diagnosis and treatment for a tuberculous damaged lung patient complicated with parvovirus B19 infection and severe thrombocytopenia

QIU Jun-ke, PAN Xiao-hong, WANG Cai-hong, MAO Min-jie()   

  1. Tuberculosis ICU, Affiliated Hangzhou Chest Hospital, Zhejiang University School of Medicine, Hangzhou 310003,China
  • Received:2021-08-10 Online:2021-12-10 Published:2021-12-01
  • Contact: MAO Min-jie E-mail:maominjie0909@163.com

摘要:

2021年1月16日,浙江大学医学院附属杭州市胸科医院结核ICU收治1例20岁女性结核性毁损肺并发细小病毒B19感染和可疑噬血细胞综合征致重度血小板减少症患者。该患者因“咳嗽伴消瘦3个月,黑便15d,加重伴鼻出血2d”入住我院。经完善实验室和影像学、骨髓穿刺活检及骨髓液病原微生物宏基因组检测等检查后,诊断为重度贫血、左侧结核性毁损肺、呼吸衰竭、细胞免疫功能障碍、重度血小板减少原因待查、细小病毒B19感染、可疑噬血细胞综合征(死亡后疑诊)。予抗结核、抗感染、输注红细胞悬液及血小板和血浆、免疫球蛋白冲击治疗后,病情未见好转。于入院第5日因呼吸衰竭加重而应用体外膜氧合技术后病情有所缓解,但在次日突然因右侧胸腔出现气胸且压缩右肺约50%而导致双肺呼吸功能基本丧失,在血小板持续低下、凝血功能未能改善的情况下,患者最终因难以纠正的呼吸衰竭、气道和消化道大量出血而死亡。笔者认为当结核性毁损肺患者并发血小板明显减少时,须积极寻找血小板减少原因;当同时并发细胞免疫功能抑制时,应考虑是否并发了机会性感染;当血小板减少症原因不明、难以纠正,且并发机会性感染时,应高度警惕噬血细胞综合征的发生。

关键词: 结核,肺, 危重病人医疗, 呼吸功能不全, 细小病毒B19,人, 血小板减少

Abstract:

The clinical diagnosis and treatment process of a case of 20-year-old female admitted to the tuberculosis ICU department of Affiliated Hangzhou Chest Hospital, Zhejiang University School of Medicine on January 16,2021 were analyzed. The patient with tuberculous damaged lung complicated with parvovirus B19 infection and severe thrombocytopenia caused by suspected hemophagocytic syndrome. The patient was admitted to the hospital with chief complaint of cough with weight loss for 3 months, black stool for 15 days, aggravation with epistaxis for 2 days. Based on laboratory test, imaging,bone marrow biopsy and metagenomic detection of pathogenic microorganisms of bone marrow fluid, the patient was diagnosed as severe anemia, left tuberculous damaged lung, respiratory failure, cellular immune dysfunction, severe thrombocytopenia with unknown cause, parvovirus B19 infection and suspected hemophagocytic syndrome (suspected after death). After anti-tuberculosis, anti-infection, infusion of erythrocyte suspension, platelet, plasma and immunoglobulin pulse therapy, the condition was not improved. On the 5th day of admission, the condition was relieved after the application of extracorporeal membrane oxygenation due to aggravation of respiratory failure. However, respiratory failure aggravated due to pneumothorax in the right lung on the next day. In the condition of persistent thrombocytopenia and failure to improve coagulation function,the patient eventually died of respiratory failure and massive hemorrhage of airway and digestive tract. We believe that when tuberculous damaged lung is complicated with obvious thrombocytopenia, the cause of thrombocytopenia should be actively find; when combined with inhibition of cellular immune function, it shoule be considered whether opportunistic infection is complicated; when with the cause of thrombocytopenia is unknown and difficult to correct, and complicated with opportunistic infection, the occurrence of hemophagocytic syndrome should be highly vigilant.

Key words: Tuberculosis,pulmonary, Critical care, Respiratory insufficiency, Parvovirus B19,human, Thrombocytopenia